Care

States Spend Millions on Private Firms to Cut Public Benefits
Care States Spend Millions on Private Firms to Cut Public Benefits

The traditional mission of the American safety net is currently undergoing a radical transformation as state governments allocate massive portions of their budgets to private technology firms. This unprecedented redirection of public funds serves a singular, paradoxical purpose: building complex

Cancer Survivors Face High Costs and Lifelong Medical Debt
Care Cancer Survivors Face High Costs and Lifelong Medical Debt

The ringing of a brass bell traditionally signifies the end of a patient’s grueling journey through oncology wards, yet for millions of Americans, that celebratory sound is immediately followed by the silent, crushing weight of a financial burden that persists for decades. This moment of triumph, w

FDA Approves Otarmeni to Treat Genetic Hearing Loss
Care FDA Approves Otarmeni to Treat Genetic Hearing Loss

A newborn infant resting in a quiet nursery currently possesses a world of silent potential that was once destined to remain forever beyond the reach of biological intervention. For decades, the standard of care for congenital deafness has been the cochlear implant, a marvel of engineering that

Why Are Medigap Premiums Rising So Fast for Seniors?
Care Why Are Medigap Premiums Rising So Fast for Seniors?

The Medicare supplemental market is currently navigating a period of unprecedented volatility that is fundamentally reshaping the financial security of American retirees. While Medigap policies have long served as a predictable buffer against the "uncapped" costs of traditional Medicare,

Trend Analysis: Hybrid Digital Health Delivery Models
Care Trend Analysis: Hybrid Digital Health Delivery Models

The traditional white-walled clinic is no longer the sole gateway to medical expertise, as patients increasingly expect care to meet them in the environments where they live, work, and learn. Healthcare delivery has undergone a fundamental transformation, moving beyond emergency virtual pivots

FDA Approves Merck’s New Once-Daily HIV Treatment Idvynso
Care FDA Approves Merck’s New Once-Daily HIV Treatment Idvynso

The recent regulatory clearance of a novel therapeutic option marks a definitive departure from the historical reliance on aggressive multi-drug cocktails for the lifelong management of human immunodeficiency virus. Merck’s newly approved medication, Idvynso, represents a strategic evolution in c

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later